In this study, the first steps in the development of a secondary reference measurement procedure (RMP) "higher metrological order measurement procedure" to support the cardiac troponin I (cTnI) standardization initiative is described. The RMP should be used to assign values to serumbased secondary reference materials (RMs) without analytical artifacts causing bias. A multiplexed bead-based assay and sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) were used to identify the optimum monoclonal antibody pair (clones 560 and 19C7) for the RMP. Using these antibodies, an ELISA-based procedure was developed to accurately measure the main cTnI forms present in blood. The proposed RMP appears to show no bias when tested on samples containing various troponin complexes, phosphorylated and dephosphorylated forms, and heparin. The candidate assay displayed suitable linearity and sensitivity (limit of detection, 0.052 mg/L) for the measurement of the proposed cTnI secondary RMs. Preliminary comparison data on patient samples with a commercial cTnI assay are also provided to support the suitability of RMP for value assignment to RMs. Full validation and final assessment of the RMP will be performed through transferability and intercomparison studies.

NOBLE James E.;  BUNK David;  CHRISTENSON Robert;  COLE Kenneth;  HE Hua-Jun;  KATRUKHA Alexei;  PANTEGHINI M.;  PORTER Robert A.;  SCHIMMEL Heinz;  TATE Jill;  WANG Lili; 

2010-11-30

WALTER DE GRUYTER & CO

JRC59173

1434-6621,   

https://publications.jrc.ec.europa.eu/repository/handle/JRC59173,   

10.1515/CCLM.2010.316,